Supritha A Shetty, MD | |
3928 Washington Rd Ste 220, Mc Murray, PA 15317-2594 | |
(724) 941-8877 | |
(724) 941-4745 |
Full Name | Supritha A Shetty |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 32 Years |
Location | 3928 Washington Rd Ste 220, Mc Murray, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164410585 | NPI | - | NPPES |
014314 | Other | PA | MEDICARE INDIVIDUAL |
185138 | Other | PA | HEALTH AMERICA INDIVIDUAL |
229426 | Other | PA | ADVANTRA GRP PROVIDER # PATEL MED ASSOC |
001545760 | Other | PA | HIGHMARK GRP PROVIDER # PATEL MED ASSOC |
04400111000 | Medicaid | WV | |
186004 | Other | PA | ADVANTRA INDIVIDUAL |
P002253 | Other | PA | GATEWAY HP GRP PROVIDER # PATEL MED ASSOC |
1504772 | Other | PA | GATEWAY HP INDIVIDUAL |
229409 | Other | PA | HEALTH AMERICA GRP PROVIDER # PATEL MED ASSOC |
3378423 | Other | PA | AETNA GRP PROVIDER # PATEL MED ASSOC |
110245304 | Other | PA | RAILROAD MC INDIVIDUAL |
2147180 | Medicaid | OH | |
0017021060005 | Medicaid | PA | |
075827 | Other | PA | MEDICARE GROUP FOR PATEL MED ASSOC |
210966 | Other | PA | UPMC HP GRP # PATEL MED ASSOC |
1414361 | Other | PA | HIGHMARK INDIVIDUAL PROVIDER NUMBER |
207165 | Other | PA | UPMC HP INDIVIDUAL |
229409 | Other | PA | HEALTH ASSURANCE GRP # PATEL MED ASSOC |
DA9375 | Other | PA | RAILROAD MC GRP # PATEL MED ASSOC |
1037778 | Other | PA | AETNA INDIVIDUAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 20986 (West Virginia) | Secondary |
207R00000X | Internal Medicine | MD065791L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Gallagher Home Health Services | Bridgeville, PA | Home health agency |
Tcm Home Health | Washington, PA | Home health agency |
Gallagher Hospice, Llc | Bridgeville, PA | Hospice |
St Clair Hospital | Pittsburgh, PA | Hospital |
Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
Preferred Primary Care Physicians, Inc. | 8527967256 | 92 |
News Archive
Doctors are more apt to recommend a more costly therapy to patients if it were determined to prolong the patient's life rather than just improve quality, according to a recent study from Medical Decision Making (published by SAGE).
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
A new injectable "biogel" is effective in delivering anti-cancer agents directly into cancerous tumours and killing them. This technology, developed by researchers at the University of Montreal Hospital Research Centre, has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionize treatment for many forms of cancer.
Raytheon Professional Services LLC, a subsidiary of Raytheon Company, and Baptist Health have signed an agreement to deliver Synergistic Medical and Resource Team training to health care systems.
› Verified 1 days ago
Entity Name | Preferred Primary Care Physicians, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407826019 PECOS PAC ID: 8527967256 Enrollment ID: O20040102000049 |
News Archive
Doctors are more apt to recommend a more costly therapy to patients if it were determined to prolong the patient's life rather than just improve quality, according to a recent study from Medical Decision Making (published by SAGE).
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
A new injectable "biogel" is effective in delivering anti-cancer agents directly into cancerous tumours and killing them. This technology, developed by researchers at the University of Montreal Hospital Research Centre, has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionize treatment for many forms of cancer.
Raytheon Professional Services LLC, a subsidiary of Raytheon Company, and Baptist Health have signed an agreement to deliver Synergistic Medical and Resource Team training to health care systems.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Supritha A Shetty, MD 701 Technology Dr Ste 150, Canonsburg, PA 15317-9531 Ph: (412) 531-2902 | Supritha A Shetty, MD 3928 Washington Rd Ste 220, Mc Murray, PA 15317-2594 Ph: (724) 941-8877 |
News Archive
Doctors are more apt to recommend a more costly therapy to patients if it were determined to prolong the patient's life rather than just improve quality, according to a recent study from Medical Decision Making (published by SAGE).
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
A new injectable "biogel" is effective in delivering anti-cancer agents directly into cancerous tumours and killing them. This technology, developed by researchers at the University of Montreal Hospital Research Centre, has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionize treatment for many forms of cancer.
Raytheon Professional Services LLC, a subsidiary of Raytheon Company, and Baptist Health have signed an agreement to deliver Synergistic Medical and Resource Team training to health care systems.
› Verified 1 days ago
Michael J Heise, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Gallery Dr Ste 300, Mc Murray, PA 15317 Phone: 724-941-7144 Fax: 724-941-7625 | |
David Albert Celko, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Valleybrook Rd, Suite 300, Mc Murray, PA 15317 Phone: 724-941-5588 Fax: 724-941-1458 | |
Dr. Thomas Francis Weir, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 802 Sheriffs Ct, Mc Murray, PA 15317 Phone: 724-470-8281 | |
Dr. William T. Ayoub, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 160 Gallery Dr, Mc Murray, PA 15317 Phone: 724-934-2550 Fax: 724-935-5558 | |
Dr. Laurie W Mathie, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Gallery Dr Ste 200, Mc Murray, PA 15317 Phone: 724-934-2550 Fax: 724-935-5558 | |
Peter Vincent Moulder Iv, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 157 Waterdam Rd Ste 120, Mc Murray, PA 15317 Phone: 724-941-7144 Fax: 724-941-7625 |